Cadila Pharmaceuticals
LeaveRussia detail: Continue Operations
Cadila Pharmaceuticals is an Indian multinational pharmaceutical company based in Ahmedabad. The company's operations focus on manufacturing products ranging from active pharmaceutical intermediates, finished formulations, food supplements, biotechnology products and pharmaceutical machinery.
Decision trail
Decision date 20/04/2023 · Reference ↗
The company continues to work in Russia. Cadila Pharmaceuticals met in 2023 with the Deputy Prime Minister of the Russian Federation and the Minister of International Relations of the Government of Moscow at a powerful bilateral industry round table in New Delhi/ 20224 hsr The Russian Direct Investment Fund (RDIF) and Cadila Pharmaceuticals Ltd., one of the leading private Indian pharmaceutical corporations, have agreed on joint investments in a project to create an innovative pharmaceutical complex and a plant for injectable drugs in Russia.
Local stats (LeaveRussia)
Status history since 2022
- 03/08/2026 — operating · Imported from KSE LeaveRussia
Exposure profile
Full exposure profile is a Professional feature
Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.
Upgrade to Professional